학술논문
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study
Document Type
Article
Author
Source
In: Inflammatory Bowel Diseases . (Inflammatory Bowel Diseases, 1 July 2022, 28(7):1034-1044)
Subject
Language
English
ISSN
15364844
10780998
10780998